The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 57.50
Ask: 60.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.217%)
Open: 59.00
High: 59.00
Low: 59.00
Prev. Close: 59.00
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

12 Sep 2023 10:30

RNS Number : 1745M
Mobeus Income & Growth 2 VCT PLC
12 September 2023
 

MOBEUS INCOME & GROWTH 2 VCT PLC

("the Company")

LEI: 213800LY62XLI1B4VX35

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2023

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 30 June 2023

(unaudited)

At 31 March 2023

(audited)

Net assets attributable to shareholders

£71,597,619

£70,426,557

Shares in issue

98,437,045

98,437,045

Net asset value (NAV) per share

72.73p

71.54p

Cumulative dividends paid

147.00p

147.00p

Cumulative Total return (net asset value basis) per share since inception

219.73p

218.54p

 

Net asset value (NAV) per share has increased by 1.19 pence, or 1.7% over the period. This increase is primarily due to a rise in unrealised valuations over the first three months of the financial year. No dividends have been paid in the period.

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investments

On 3 May 2023, a new equity investment of £0.39 million was made into Dayrize B.V., a provider of a rapid sustainability impact assessment tool.

 

Share Buybacks

No shares were bought back in the quarter.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

New investments after the period end

On 26 July 2023, a new equity investment of £0.32 million was made into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, a new equity investment of £0.32 million was made into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Follow-on investments after the period end

On 4 July 2023, a follow on equity investment of £0.30 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.11 million was made into Orri, an intensive day care provider for adults with eating disorders.

 

Share Buybacks after the period end

On 18 July 2023, the Company purchased 336,876 of its own ordinary shares at a price of 67.96 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary

020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKLLBFXKLLBBX
Date   Source Headline
26th Jan 20213:00 pmRNSReplacement - Transaction in Own Shares
11th Jan 202112:00 pmRNSRealisation of Investment
17th Dec 202011:40 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20203:23 pmRNSInterim Report
29th Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20203:58 pmRNSIMPACT OF RECENT DISPOSALS UPON NET ASSET VALUE
9th Sep 202011:05 amRNSAGM Results
8th Sep 20203:30 pmRNSInterim Management Statement to 30 June 2020
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
10th Aug 20208:54 amRNSRevised AGM Arrangements
3rd Jul 20204:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20207:00 amRNSAnnual Financial Report
14th May 20209:15 amRNSDividend Declaration
2nd Apr 20205:10 pmRNSIssue of Equity
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
23rd Mar 202011:30 amRNSTransaction in Own Shares
2nd Mar 202010:23 amRNSInterim Management Statement to 31 December 2019
28th Feb 20201:09 pmRNSFundraising Update
26th Feb 20202:48 pmRNSInterim Dividend
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
6th Feb 20203:45 pmRNSOffer Increase
3rd Feb 202011:30 amRNSTotal Voting Rights
13th Jan 202011:00 amRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20193:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
12th Dec 201912:40 pmRNSTransaction in Own Shares
28th Nov 201910:15 amRNSHalf-Year Report for the six months ended 30/09/19
20th Nov 20191:00 pmRNSHalf-year Report
5th Nov 20194:00 pmRNSReduction of Capital
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
11th Sep 201912:41 pmRNSResult of AGM
10th Sep 20195:00 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.